COCONUT Study Concomitant PVI and LAAC
Recruiting · NCT06861673 · Observational (researchers observe without assigning treatment) · Lead sponsor: Asklepios proresearch
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
In patients with non-valvular AF, at high stroke risk, and who are ineligible for long-term oral anticoagulation LAAC could be an alternative to anticoagulation and safety and efficacy has been shown in several studies and registries.8 While PVI and LAAC are both conducted in the left atrium and share the same access route, a combined concomitant approach might be beneficial for patients but is not conventionally practiced. Due to significantly shorter procedures times and high safety profile PFA based catheter ablation may be advantageous for the combined approach of PVI and LAAC. We are performing a word-wide, retrospective, multicenter registry study focusing on patients with concomitant Farapulse PFA based PVI and LAAC (WATCHMAN Flx, Boston Scientific). To evaluate safety, efficacy and efficiency in a multicenter study the COCONUT study was conducted.
Who can take part
Inclusion criteria
- Indicatio for PVI and LAAC
Exclusion criteria
- Not eligible for any of the procedures PVI and LAAC
Where it is running
1 location listed.
- Asklepios Klinik Altona - Hamburg, Free and Hanseatic City of Hamburg, Germany